Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis Inc. is projected to experience significant revenue growth across its major streams, with estimated increases of 24% for systems, 20% for disposables, and 25% for service and accessories by FY26, driven by greater system adoption and catheter utilization. The company's remarkable performance in the second quarter, showcasing a 95% year-over-year revenue increase to $8.8 million, alongside a robust 35% rise in recurring revenue, underscores its strong market position and demand for innovative products such as the Map-iT and MAGiC catheters. Furthermore, Stereotaxis's regulatory advancements and successful product launches position it for enhanced business leverage and the expectation of exceeding $10 million in average quarterly revenue by FY26, further reinforcing a positive financial outlook.

Bears say

Stereotaxis Inc. faces a negative outlook primarily due to significant operational challenges, including delays in product approvals and ongoing supply issues with essential catheters, which may adversely affect revenue projections. The company's net loss of $3.8 million reflects its current financial struggles further compounded by the need to seek additional financing within a two-year cash runway to support its sales infrastructure and operational expenses. Additionally, the potential for reduced reimbursement rates, competition from both manual and robotic systems, and slower adoption rates internationally present further risks that could hinder the company's profitability trajectory and overall financial performance.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.